BXT-25 is capable of perfusing clots in brain and heart. FDA approval process is based on easily defined surrogate markers. There’s an enormous licensing potential of...
Parents of children with serious health conditions are facing high costs of healthcare.
Preventable diseases still kill one in four people around the world. Medical science, early interventions and lifestyle changes could prevent millions of early deaths from diabetes,...
What kind of changes should people expect when it comes to the United States’ health infrastructure?
Microsoft announced a strategic partnership with Walgreens Boots Alliance, with the long-term goal of lowering the cost of health care.
Seeing the uprising number of healthcare mobile apps, are you wondering if you need to invest in one? Here are some things to consider for effective...
Eli Lilly & Co. makes second major pharmaceutical deal this year by paying cancer drug specialists Loxo Oncology $8 billion.
With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...
BPDCN is a rare disease with no known treatments. However, patients with the disease have new hope with the approval of Stemline’s Elzonris.
Effectively ending their self-imposed halt this year, drugmakers will start the new year with drug price increases.